![Amer Alghabban](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amer Alghabban
Plus aucun poste en cours
Historique de carrière de Amer Alghabban
Anciens postes connus de Amer Alghabban
Sociétés | Poste | Début | Fin |
---|---|---|---|
Medicines & Healthcare Products Regulatory Agency | Compliance Officer | - | - |
NOVARTIS AG | Comptroller/Controller/Auditor | - | - |
Arpida AG
![]() Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Corporate Officer/Principal | - | - |
MERCK KGAA | Directeur/Membre du Conseil | - | - |
Gxp Compliance &Training Partners | Directeur Général | - | - |
KARYOPHARM THERAPEUTICS INC. | Compliance Officer | 01/08/2015 | - |
Statistiques
Internationale
Suisse | 4 |
Etats-Unis | 2 |
Allemagne | 2 |
Opérationnelle
Compliance Officer | 2 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 5 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
MERCK KGAA | Health Technology |
NOVARTIS AG | Health Technology |
Entreprise privées | 3 |
---|---|
Gxp Compliance &Training Partners | |
Arpida AG
![]() Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Medicines & Healthcare Products Regulatory Agency | Government |
- Bourse
- Insiders
- Amer Alghabban
- Expérience